VENLAFAXINE HYDROCHLORIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
75834-219 -
Package NDC
75834-219-00 -
Package NDC
75834-219-30 -
Package NDC
75834-219-90 -
Application number
ANDA211323 -
SPL ID
bb5cc2c4-6d14-42aa-a9af-dc29bae4f238 -
SPL set ID
45cb4c19-fbf4-4ff5-af6f-b25a31ebc1e1 -
UNII
7D7RX5A8MO -
RxCUI
808744 -
RxCUI
808748 -
RxCUI
808753
What the source publishes
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Active ingredients
- VENLAFAXINE HYDROCHLORIDE
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "VENLAFAXINE HYDROCHLORIDE",
"splId": "bb5cc2c4-6d14-42aa-a9af-dc29bae4f238",
"labels": [
{
"setId": "45cb4c19-fbf4-4ff5-af6f-b25a31ebc1e1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45cb4c19-fbf4-4ff5-af6f-b25a31ebc1e1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45cb4c19-fbf4-4ff5-af6f-b25a31ebc1e1"
}
],
"routes": [
"ORAL"
],
"labeler": "Nivagen Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-219-00)",
"package_ndc": "75834-219-00",
"identifierStatus": "well-formed",
"marketing_start_date": "20190906"
},
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-219-30)",
"package_ndc": "75834-219-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20190906"
},
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-219-90)",
"package_ndc": "75834-219-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20190906"
}
],
"productId": "75834-219_bb5cc2c4-6d14-42aa-a9af-dc29bae4f238",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "75834-219",
"deaSchedule": null,
"genericName": "VENLAFAXINE HYDROCHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "VENLAFAXINE HYDROCHLORIDE",
"strength": "225 mg/1"
}
],
"applicationNumber": "ANDA211323",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190906",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0375834217000",
"0375834219004"
],
"unii": [
"7D7RX5A8MO"
],
"rxcui": [
"808744",
"808748",
"808753"
],
"spl_set_id": [
"45cb4c19-fbf4-4ff5-af6f-b25a31ebc1e1"
],
"manufacturer_name": [
"Nivagen Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:75834-219_bb5cc2c4-6d14-42aa-a9af-dc29bae4f238"